
Triathlon Medical Venture Partners
Description
Triathlon Medical Venture Partners, also known as Triathlon Medical Ventures, is a Midwest-based venture capital firm with a dedicated focus on early-stage life sciences companies. Headquartered in Cincinnati, Ohio, the firm has established itself as a significant investor in the biotechnology, medical device, diagnostics, and pharmaceutical sectors. Their investment philosophy centers on identifying companies with robust intellectual property, addressing clear unmet clinical needs, and led by experienced management teams.
The firm typically seeks to partner with companies that are past the initial concept phase and are poised for significant growth. They often take an active role in their portfolio companies, leveraging their deep industry expertise and network to provide strategic guidance and support. Triathlon Medical Venture Partners emphasizes a collaborative approach, working closely with founders to navigate the complex landscape of product development, regulatory approvals, and market commercialization.
Triathlon Medical Ventures has a history of successful fundraises, demonstrating sustained commitment to the life sciences industry. Their first fund, Triathlon Medical Ventures Fund I, L.P., was established in 2001 with capital commitments totaling $50 million. Building on this success, they launched Triathlon Medical Ventures Fund II, L.P. in 2007, which secured $100 million in capital commitments. The firm's typical initial investment ranges from $2 million to $5 million, with additional capital reserved for follow-on rounds to support the long-term growth and success of their portfolio companies.
Investor Profile
Triathlon Medical Venture Partners has backed more than 35 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 23% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Israel.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $2M – $5M.
Stage Focus
- Series B (26%)
- Series C (20%)
- Series Unknown (20%)
- Series A (17%)
- Series E (6%)
- Series D (6%)
- Series H (3%)
- Series G (3%)
Country Focus
- United States (91%)
- United Kingdom (6%)
- Israel (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Therapeutics
- Pharmaceutical
- Manufacturing
- Life Science
- Health Diagnostics
- Product Design
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.